Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells

被引:45
作者
Lee, Tae-Jin [1 ,2 ]
Sartor, Oliver [2 ,3 ]
Luftig, Ronald B. [1 ]
Koochekpour, Shahriar [1 ,2 ]
机构
[1] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA
[2] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA
[3] Louisiana State Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA 70112 USA
关键词
Apoptosis; Prosaposin; Prostate cancer; Saposin C; Survival;
D O I
10.1186/1476-4598-3-31
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: In addition to androgens, growth factors are also implicated in the development and neoplastic growth of the prostate gland. Prosaposin is a potent neurotrophic molecule. Homozygous inactivation of prosaposin in mice has led to the development of a number of abnormalities in the male reproductive system, including atrophy of the prostate gland and inactivation of mitogen-activated protein kinase (MAPK) and Akt in prostate epithelial cells. We have recently reported that prosaposin is expressed at a higher level by androgen-independent (AI) prostate cancer cells as compared to androgen-sensitive prostate cancer cells or normal prostate epithelial and stromal cells. In addition, we have demonstrated that a synthetic peptide (prosaptide TX14A), derived from the trophic sequence of the saposin C domain of prosaposin, stimulated cell proliferation, migration and invasion and activated the MAPK signaling pathway in prostate cancer cells. The biological significances of saposin C and prosaposin in prostate cancer are not known. Results: Here, we report that saposin C, in a cell type-specific and dose-dependent manner, acts as a survival factor, activates the Akt-signaling pathway, down-modulates caspase-3, -7, and -9 expression and/or activity, and decreases the cleaved nuclear substrate of caspase-3 in prostate cancer cells under serum-starvation stress. In addition, prosaptide TX14A, saposin C, or prosaposin decreased the growth-inhibitory effect, caspase-3/7 activity, and apoptotic cell death induced by etoposide. We also discovered that saposin C activates the p42/44 MAP kinase pathway in a pertussis toxin-sensitive and phosphatidylinositol 3-kinase (PI3K)/Akt-dependent manner in prostate cancer cells. Our data also show that the anti-apoptotic activity of saposin C is at least partially mediated via PI3K/Akt signaling pathway. Conclusion: We postulate that as a mitogenic, survival, and anti-apoptotic factor for prostate cancer cells, saposin C or prosaposin may contribute to prostate carcinogenesis at its early androgen-dependent or metastatic AI state.
引用
收藏
页数:14
相关论文
共 39 条
  • [1] Campana WM, 1999, J NEUROSCI RES, V57, P332
  • [2] Induction of MAPK phosphorylation by prosaposin and prosaptide in PC12 cells
    Campana, WM
    Hiraiwa, M
    Addison, KC
    OBrien, JS
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 229 (03) : 706 - 712
  • [3] Secretion of prosaposin, a multifunctional protein, by breast cancer cells
    Campana, WM
    O'Brien, JS
    Hiraiwa, M
    Patton, S
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1999, 1427 (03): : 392 - 400
  • [4] Prosaptide activates the MAPK pathway by a G-protein-dependent mechanism essential for enhanced sulfatide synthesis by Schwann cells
    Campana, WM
    Hiraiwa, M
    O'Brien, JS
    [J]. FASEB JOURNAL, 1998, 12 (03) : 307 - 314
  • [5] Chang MHY, 2000, CLIN CHEM, V46, P167
  • [6] Regulation of cyclin D1 by calpain protease
    Choi, YH
    Lee, SJ
    Nguyen, P
    Jang, JS
    Lee, J
    Wu, ML
    Takano, E
    Maki, M
    Henkart, PA
    Trepel, JB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (45) : 28479 - 28484
  • [7] Coffey RNT, 2001, CANCER-AM CANCER SOC, V92, P2297, DOI 10.1002/1097-0142(20011101)92:9<2297::AID-CNCR1576>3.0.CO
  • [8] 2-B
  • [9] Denmeade SR, 1996, PROSTATE, V28, P251
  • [10] Akt in prostate cancer: Possible role in androgen-independence
    Ghosh, PM
    Malik, S
    Bedolla, R
    Kreisberg, JI
    [J]. CURRENT DRUG METABOLISM, 2003, 4 (06) : 487 - 496